XOMA Corp

NASDAQ:XOMA USA Biotechnology
Market Cap
$334.34 Million
Market Cap Rank
#13705 Global
#5632 in USA
Share Price
$27.00
Change (1 day)
+1.47%
52-Week Range
$18.76 - $39.72
All Time High
$45.61
About

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential… Read more

XOMA Corp (XOMA) - Total Assets

Latest total assets as of September 2025: $263.15 Million USD

Based on the latest financial reports, XOMA Corp (XOMA) holds total assets worth $263.15 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

XOMA Corp - Total Assets Trend (1985–2024)

This chart illustrates how XOMA Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

XOMA Corp - Asset Composition Analysis

Current Asset Composition (December 2024)

XOMA Corp's total assets of $263.15 Million consist of 56.8% current assets and 43.2% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 45.9%
Accounts Receivable $17.02 Million 7.7%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $25.91 Million 11.7%
Goodwill $0.00 0.0%

Asset Composition Trend (1985–2024)

This chart illustrates how XOMA Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: XOMA Corp's current assets represent 56.8% of total assets in 2024, a decrease from 60.4% in 1985.
  • Cash Position: Cash and equivalents constituted 45.9% of total assets in 2024, down from 57.1% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 1985.
  • Asset Diversification: The largest asset category is intangible assets at 11.7% of total assets.

XOMA Corp Competitors by Total Assets

Key competitors of XOMA Corp based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

XOMA Corp - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.02 - 1.17

Lower asset utilization - XOMA Corp generates 0.13x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -186.67% - 32.48%

Negative ROA - XOMA Corp is currently not profitable relative to its asset base.

XOMA Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.91 7.52 7.16
Quick Ratio 3.91 7.64 7.03
Cash Ratio 0.00 0.00 0.00
Working Capital $82.40 Million $ 137.89 Million $ 75.76 Million

XOMA Corp - Advanced Valuation Insights

This section examines the relationship between XOMA Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.98
Latest Market Cap to Assets Ratio 1.16
Asset Growth Rate (YoY) -5.6%
Total Assets $221.28 Million
Market Capitalization $255.80 Million USD

Valuation Analysis

Above Book Valuation: The market values XOMA Corp's assets above their book value (1.16 x), reflecting positive investor sentiment about the company's future prospects.

Significant Asset Reduction: XOMA Corp's assets decreased by 5.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for XOMA Corp (1985–2024)

The table below shows the annual total assets of XOMA Corp from 1985 to 2024.

Year Total Assets Change
2024-12-31 $221.28 Million -5.56%
2023-12-31 $234.30 Million +66.90%
2022-12-31 $140.38 Million -15.72%
2021-12-31 $166.56 Million +32.95%
2020-12-31 $125.28 Million +30.88%
2019-12-31 $95.72 Million +50.07%
2018-12-31 $63.78 Million +41.95%
2017-12-31 $44.94 Million +56.69%
2016-12-31 $28.68 Million -61.70%
2015-12-31 $74.88 Million -16.46%
2014-12-31 $89.63 Million -33.50%
2013-12-31 $134.78 Million +27.54%
2012-12-31 $105.68 Million +35.42%
2011-12-31 $78.04 Million +5.10%
2010-12-31 $74.25 Million +40.56%
2009-12-31 $52.82 Million -21.36%
2008-12-31 $67.17 Million -20.80%
2007-12-31 $84.81 Million -7.28%
2006-12-31 $91.48 Million +26.04%
2005-12-31 $72.58 Million +56.89%
2004-12-31 $46.26 Million -61.08%
2003-12-31 $118.85 Million +65.57%
2002-12-31 $71.78 Million -16.64%
2001-12-31 $86.11 Million +90.45%
2000-12-31 $45.21 Million +59.76%
1999-12-31 $28.30 Million -24.13%
1998-12-31 $37.30 Million -42.44%
1997-12-31 $64.80 Million +12.31%
1996-12-31 $57.70 Million +41.08%
1995-12-31 $40.90 Million -34.46%
1994-12-31 $62.40 Million -33.69%
1993-12-31 $94.10 Million -13.91%
1992-12-31 $109.30 Million -29.16%
1991-12-31 $154.30 Million +59.07%
1990-12-31 $97.00 Million -12.22%
1989-12-31 $110.50 Million +100.91%
1988-12-31 $55.00 Million -17.29%
1987-12-31 $66.50 Million +40.30%
1986-12-31 $47.40 Million +218.12%
1985-12-31 $14.90 Million --